BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12824579)

  • 1. High-throughput screens based on NAD(P)H depletion.
    Glieder A; Meinhold P
    Methods Mol Biol; 2003; 230():157-70. PubMed ID: 12824579
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a cytochrome P450BM3 reaction system linked by two-step cofactor regeneration catalyzed by a soluble transhydrogenase and glycerol dehydrogenase.
    Mouri T; Shimizu T; Kamiya N; Goto M; Ichinose H
    Biotechnol Prog; 2009; 25(5):1372-8. PubMed ID: 19725101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating a screen and analysis of mutant libraries.
    Salazar O; Sun L
    Methods Mol Biol; 2003; 230():85-97. PubMed ID: 12824571
    [No Abstract]   [Full Text] [Related]  

  • 8. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.
    Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD
    Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of P450(BM-3) whole-cell biocatalysis by integrating heterologous cofactor regeneration combining glucose facilitator and dehydrogenase in E. coli.
    Schewe H; Kaup BA; Schrader J
    Appl Microbiol Biotechnol; 2008 Feb; 78(1):55-65. PubMed ID: 18057930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the domain structure of cytochrome P450 102 (BM-3): isolation and properties of a 45-kDa FAD/NADP domain.
    Black SD
    Biochem Biophys Res Commun; 1994 Aug; 203(1):162-8. PubMed ID: 8074651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
    Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
    Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P450BM-3: reduction by NADPH and sodium dithionite.
    Peterson JA; Boddupalli SS
    Arch Biochem Biophys; 1992 May; 294(2):654-61. PubMed ID: 1567220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recombinant Bacillus megaterium cytochrome P-450 BM-3 and its two functional domains.
    Li HY; Darwish K; Poulos TL
    J Biol Chem; 1991 Jun; 266(18):11909-14. PubMed ID: 1904873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing inter-domain electron transfer in a model flavocytochrome P-450.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S629. PubMed ID: 9450057
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents.
    Eiben S; Bartelmäs H; Urlacher VB
    Appl Microbiol Biotechnol; 2007 Jul; 75(5):1055-61. PubMed ID: 17468867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
    Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
    Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkane metabolism by cytochrome P450 BM3.
    Munro AW; Lindsay JG; Coggins JR
    Biochem Soc Trans; 1993 Nov; 21(4):412S. PubMed ID: 8131986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.